DNALITE THERAPEUTICS
DNALite Therapeutics is an early-stage preclinical biotechnology company committed to bringing the next generation of drugs to the gastrointestinal tract. It develops oral lipid nanoparticle technology to deliver mRNA and pDNA into the intestine using the oral route of administration. Its drug aims to use the intestinal tract to secrete proteins into the bloodstream turning any protein biologic into an oral drug.
DNALITE THERAPEUTICS
Industry:
Biotechnology Genetics Health Care
Founded:
2016-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.dnalite.com
Total Employee:
11+
Status:
Active
Total Funding:
7.32 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Google Apps For Business GoDaddy DNS Pound Sterling
Similar Organizations
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Neumora Therapeutics
Neumora Therapeutics operates as a clinical-stage biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
SOSV
SOSV investment in Series A - DNALite Therapeutics
IndieBio
IndieBio investment in Series A - DNALite Therapeutics
IndieBio
IndieBio investment in Convertible Note - DNALite Therapeutics
SOSV
SOSV investment in Convertible Note - DNALite Therapeutics
SOSV
SOSV investment in Seed Round - DNALite Therapeutics
IndieBio
IndieBio investment in Seed Round - DNALite Therapeutics
National Science Foundation
National Science Foundation investment in Grant - DNALite Therapeutics
SOSV
SOSV investment in Seed Round - DNALite Therapeutics
University of California Berkeley
University of California Berkeley investment in Seed Round - DNALite Therapeutics
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Seed Round - DNALite Therapeutics
Official Site Inspections
http://www.dnalite.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
